首頁 > 市場調查報告書 > 醫療設備

病患監測血糖監測

市場調查報告書

商品編碼

1845674

非侵入性血糖監測市場（按產品類型、應用、技術、最終用戶和地區）2024 年至 2031 年

Non-Invasive Glucose Meter Market By Product Type, Application, Technology, End-User, Region for 2024-2031

出版日期: 2025年09月08日 | 出版商:

Verified Market Research | 英文 202 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

非侵入性血糖儀市場評估 - 2024-2031

全球糖尿病盛行率的上升，正在增加全球對非侵入性血糖儀等微創設備的需求。因此，生活方式的改變、久坐不動的生活方式、不良飲食習慣以及遺傳因素正在推動非侵入性血糖儀的銷售。糖尿病盛行率的上升正推動市場規模呈指數級成長，預計到2024年將超過1.6365億美元，到2031年將達到2.77億美元。

預計非侵入式連續血糖監測市場將持續成長，這得益於消費者健康意識的提升以及技術先進產品的廣泛應用，這些因素預計將成為主要驅動力。因此，對非侵入式連續血糖監測日益成長的偏好預計將推動該市場在2024年至2031年間以6.80%的複合年成長率成長。

非侵入式血糖儀市場定義/概述

非侵入性血糖儀是糖尿病管理技術領域的革命性工具，無需刺穿皮膚即可測量血糖值。與需要刺穿手指的傳統血糖儀不同，這些設備採用光譜和無線電波等非侵入式方法來分析皮下液體和組織。這種無痛便捷的方法改善了糖尿病患者的使用體驗。

這些血糖儀的主要目的是為糖尿病患者提供一種舒適易用的血糖值監測方式。便捷的操作有助於持續頻繁地監測，這對於有效的糖尿病管理至關重要。這有助於及早發現血糖值波動並及時干預。非侵入式監測還可以改善血糖控制，並預防與糖尿病相關的長期併發症，例如心血管疾病、神經病變和視網膜病變。

糖尿病患者意識的提高將如何推動非侵入式血糖儀市場的成長？

隨著糖尿病患者越來越意識到定期監測血糖的重要性，非侵入性血糖儀市場正在不斷擴大。醫療保健計劃、教育宣傳活動以及全球糖尿病疫情的推動也推動了這個市場的發展。光譜法、電阻測量法和光同調斷層掃瞄(OCT) 等非侵入性血糖監測設備的技術進步，正在徹底改變血糖儀的準確性、可靠性和使用者體驗。這些最尖端科技使患者能夠輕鬆監測血糖濃度，避免了傳統侵入式方法的不適和不便。

由於傳統的指尖採血操作既不舒服又不方便，人們對無痛便捷的血糖監測解決方案的需求日益成長。非侵入性血糖儀提供了一種極具吸引力的替代方案，它無需頻繁進行皮膚採血，使監測過程更加舒適。這種身體不適感的減少可以鼓勵糖尿病患者更規律地監測血糖，這對於有效的疾病管理和改善健康至關重要。

非侵入式血糖監測設備在家庭護理環境中的日益普及，將使患者能夠在家中舒適地監測血糖值，從而更積極地管理自身健康。全球人口老化的發展也推動了非侵入式血糖儀市場的擴張，因為老齡化人群患糖尿病及其相關併發症的風險更高。

優惠的報銷政策和政府推動有效糖尿病管理的舉措進一步推動了市場成長。隨著全球糖尿病發病率持續上升，對便捷有效的血糖監測解決方案的需求預計將進一步推動市場擴張。

缺乏認知和懷疑態度將如何阻礙非侵入性血糖監測市場的成長？

非侵入性血糖儀市場面臨許多挑戰，包括糖尿病患者對這些設備的準確性和可靠性的質疑、醫療專業人員認知度的差距、監管挑戰、來自替代血糖監測解決方案的日益激烈的競爭以及經濟因素。傳統的侵入式血糖儀方法，例如指尖採血和抽血，因其可靠性和廣泛接受度而仍然廣受歡迎。此外，巨大的教育差距阻礙了患者充分了解非侵入性血糖儀的潛在益處。醫療專業人員也可能因為不熟悉該技術或對其有效性存在擔憂而猶豫是否支持非侵入性血糖儀技術。

嚴格的要求和冗長的核准流程等監管挑戰可能會延遲新產品的推出，並阻礙商業化進程。對於尋求全球產品上市的製造商來說，應對不同地區不同監管環境的複雜性進一步加劇了這個過程。

此外，市場還面臨著來自持續血糖監測系統和植入式血糖感測器等新興技術的日益激烈的競爭，這些技術通常被認為更先進、更準確。這些替代技術加劇了競爭格局，使非侵入式血糖監測更難獲得市場佔有率。

價格壓力和報銷限制等經濟因素也限制非侵入式血糖儀市場的成長。製造商必須平衡定價策略，確保價格可負擔的同時保持盈利，而這在注重成本的醫療保健系統中很難實現，因為報銷限制會限制患者獲得非侵入式血糖監測設備。預計這將導致單位銷售額下降和市場成長放緩。

Abbott（US）
PHC Holdings Corporation（Japan）
Sanofi（France）
Dexcom, Inc（US）
Medtronic（Ireland）
B. Braun SE（Germany）
F. Hoffmann-La Roche Ltd（Switzerland）
LifeScan（US）
Ascensia Diabetes Care Holdings AG（Switzerland）
AgaMatrix（US）
DarioHealth（Israel）
Becton Dickinson and Company（US）

第11章市場展望與機遇

新興技術
未來市場趨勢
投資機會

第12章附錄

簡稱列表
來源和參考文獻

簡介目錄

Product Code: 80486

Non-Invasive Glucose Meter Market Valuation - 2024-2031

The global demand for minimally invasive devices, such as non-invasive glucose meters, is increasing due to the rising prevalence of diabetes worldwide. Thus, the changing lifestyle habits, sedentary lifestyles, poor dietary choices, and genetic factors are factors likely to boost the sales of non-invasive glucose meter. 'The increasing prevalence of diabetes is surging the growth of the market size surpassing USD 163.65 Million in 2024 to reach a valuation of USD 277 Million by 2031.

The non-invasive continuous glucose monitoring market is expected to grow due to rising health consciousness among consumers and widespread adoption of technologically advanced products, which are expected to be major contributors. Thus, the increasing preference for non-invasive continuous glucose monitoring enables the market to grow at a CAGR of 6.80% from 2024 to 2031.

Non-Invasive Glucose Meter Market: Definition/ Overview

A non-invasive glucose meter is a revolutionary tool in diabetes management technology that measures blood sugar levels without skin penetration. Unlike traditional glucose meters that require finger pricking, these devices use non-invasive methods like spectroscopy and radio waves to analyze body fluids or tissues beneath the skin's surface. This painless and convenient method enhances the user experience for diabetic patients.

The primary purpose of these meters is to empower individuals with diabetes by providing a comfortable and user-friendly way to monitor their blood glucose levels. The ease of use encourages consistent and frequent monitoring, which is crucial for effective diabetes management. This leads to earlier detection of blood sugar fluctuations and timely interventions. Non-invasive monitoring can also improve glycemic control, preventing long-term complications associated with diabetes, such as cardiovascular diseases, neuropathy, and retinopathy.

How Does the Rising Awareness Among Diabetic Patients Surge the Growth of the Non-Invasive Glucose Meter Market?

The non-invasive glucose meter market is expanding due to increasing awareness among diabetic patients about the importance of regular glucose monitoring. This is driven by healthcare initiatives, educational campaigns, and the global prevalence of diabetes. Technological advancements in non-invasive glucose monitoring devices, such as spectroscopy, impedance-based measurements, and optical coherence tomography (OCT), are revolutionizing the accuracy, reliability, and user experience of glucose meters. These cutting-edge technologies make it easier for patients to monitor their glucose levels without the discomfort and inconvenience traditionally associated with invasive methods.

The demand for painless and convenient glucose monitoring solutions is on the rise, as traditional finger pricks and blood draws are uncomfortable and inconvenient. Non-invasive glucose meters offer a compelling alternative by eliminating the need for frequent skin punctures, making the monitoring process more comfortable. This reduction in physical discomfort encourages diabetic patients to engage in more regular blood sugar monitoring, essential for effective disease management and improved health outcomes.

The increasing adoption of non-invasive glucose meters in homecare settings allows patients to monitor their glucose levels in the comfort of their own homes, empowering them to take a more proactive role in managing their health. The growing global geriatric population is also driving the expansion of the non-invasive glucose meter market, as they are at a higher risk of developing diabetes and its associated complications.

Favorable reimbursement policies and government initiatives promoting effective diabetes management are further fostering market growth. As diabetes continues to rise globally, the need for convenient and effective glucose monitoring solutions is expected to further accelerate market expansion.

How will the Lack of Awareness and Skepticism Hamper the Growth of Non-Invasive Glucose Meter Market?

The non-invasive glucose meter market faces several challenges, including skepticism among diabetic patients about the accuracy and reliability of these devices, a gap in awareness among healthcare professionals, regulatory challenges, increasing competition from alternative glucose monitoring solutions, and economic factors. Traditional invasive methods like finger pricks and blood draws remain popular due to their reliability and widespread acceptance. Additionally, there is a significant educational gap that prevents patients from fully appreciating the potential benefits of non-invasive methods. Healthcare professionals may also be hesitant to endorse non-invasive meters due to unfamiliarity with the technology or concerns about their effectiveness.

Regulatory challenges, such as stringent requirements and lengthy approval processes, can delay the introduction of new products, hindering commercialization efforts. The complexity of navigating diverse regulatory landscapes across different regions further complicates the process for manufacturers seeking to launch their products globally.

Additionally, the market is facing increasing competition from emerging technologies like continuous glucose monitoring systems and implantable glucose sensors, which are often seen as more advanced or accurate. These alternatives intensify the competitive landscape, making it more challenging for non-invasive options to gain market share.

Economic factors, such as pricing pressures and reimbursement limitations, also constrain the growth of the non-invasive glucose meter market. Manufacturers must balance pricing strategies to ensure affordability while remaining profitable, but this is difficult to achieve in cost-conscious healthcare systems where reimbursement constraints can limit patient access to non-invasive glucose monitoring devices. This is projected to lead to reduced sales volumes and slower market growth.

Category-Wise Acumens

How did the Adoption of Wearable Glucose Monitoring Surge the Growth of the Wearable Devices Segment?

The wearable devices segment is dominating segment in the non-invasive glucose meter market due to advancements in healthcare and technology. These devices offer compact, discreet, and real-time data tracking, revolutionizing diabetes management by providing convenience and minimal disruption to daily life. The compact design and ease of use enable patients to integrate these devices into their routines, improving adherence to monitoring regimens.

The growing trend towards remote patient monitoring and telehealth services is another significant factor contributing to the rising demand for wearable glucose meters. Wearable glucose meters empower patients by allowing them to continuously track their glucose levels and transmit the data to healthcare professionals in real time, facilitating timely interventions, personalized treatment plans, and proactive diabetes management.

The integration of wearable glucose meters with smartphone applications and cloud-based platforms enhances data accessibility and usability. These devices can sync seamlessly with mobile apps, enabling patients to easily view and analyze their glucose data. Cloud-based platforms offer a centralized location for accessing patient data, making it easier to monitor trends, adjust treatment plans, and provide personalized care.

The increasing prevalence of diabetes globally and the demand for continuous glucose monitoring solutions are pivotal in driving the adoption of wearable devices. By offering real-time insights into glucose levels, these devices help patients maintain better glycemic control, reducing the risk of complications such as cardiovascular disease, neuropathy, and retinopathy.

How Advanced Techniques and Highly Accurate Glucose Level Measurement Foster the Growth of Spectroscopy-based Segment?

Spectroscopy-based meters are a popular choice for diabetic patients and healthcare providers due to their advanced technology, near-infrared (NIR) spectroscopy, which provides highly accurate glucose level measurements. This precision allows patients to make informed decisions about their treatment regimens and lifestyle adjustments, leading to better health outcomes.

The simplicity and ease of use of spectroscopy-based meters make them accessible to a wide range of users, including elderly individuals and those with limited mobility or dexterity. This ease of use promotes adherence to glucose monitoring regimens, essential for managing diabetes effectively.

Continuous monitoring of glucose levels provides patients with valuable insights into their blood sugar levels, enabling early detection of significant changes and timely interventions to prevent severe episodes of hyperglycemia or hypoglycemia. The real-time monitoring feature is particularly beneficial for patients who need to closely manage their glucose levels due to volatile or unpredictable patterns.

Spectroscopy-based meters are often integrated with mobile applications and cloud-based platforms, enhancing the accessibility and usability of the data generated. Patients can easily sync their glucose data to their smartphones or tablets, allowing them to track trends, set reminders, and share information with healthcare providers.

The compact and portable design of spectroscopy-based meters enhances their convenience, allowing patients to monitor their glucose levels on the go, especially for those with active lifestyles. This enables more effective and flexible diabetes management, empowering individuals to maintain control over their health regardless of their location.

Country/Region-wise Acumens

How the Increasing Adoption of Non-Invasive Glucose Meter Foster the Growth of Non-Invasive Glucose Meter Market in North America?

North America dominates the non-invasive glucose meter market due to the high prevalence of diabetes and growing awareness of the importance of regular glucose monitoring. The region's advanced healthcare infrastructure and favorable reimbursement policies support the widespread adoption of non-invasive glucose meters. Healthcare providers in North America are increasingly recognizing the benefits of these devices, which improve patient outcomes and reduce costs associated with diabetes management. Government initiatives, such as public health campaigns, educational programs, and financial incentives, contribute to a heightened focus on proactive diabetes management.

The emphasis on technological innovation and research and development in this region is also driving market growth. Leading medical device companies and research institutions are at the forefront of advancing non-invasive glucose monitoring technologies, investing heavily in the development of cutting-edge products with enhanced accuracy, reliability, and user-friendliness. The continuous introduction of these advanced devices fuels market demand and accelerates their adoption across the healthcare landscape.

The growing trend toward telehealth and remote patient monitoring services in North America is also boosting the demand for non-invasive glucose meters. These devices allow patients to conveniently monitor their glucose levels at home and share real-time data with their healthcare providers, enabling timely interventions and personalized treatment plans. Overall, North America's healthcare infrastructure and focus on innovation and research contribute to its dominance in the non-invasive glucose meter market.

How Does the Increasing Diabetic Population in Asia Pacific Foster the Growth of the Non-Invasive Glucose Meter Market?

The Asia Pacific region is expected to experience the fastest growth in the non-invasive glucose meter market due to the increasing diabetic population and growing awareness of the importance of regular glucose monitoring. Rapid economic development and urbanization are playing a crucial role in this anticipated market expansion.

As countries continue to develop economically, access to healthcare services improves and healthcare expenditure increases, making advanced medical technologies, including non-invasive glucose meters, more accessible to a broader segment of the population. The growing acceptance and adoption of these devices among healthcare providers and patients further fuels market growth.

Government initiatives aimed at addressing the growing burden of diabetes are another key factor driving the non-invasive glucose meter market in the Asia Pacific. Governments are implementing public health campaigns, educational programs, and subsidized healthcare services to raise awareness about diabetes management and the importance of regular glucose monitoring.

Favorable regulatory policies and reimbursement schemes in many countries facilitate market access for manufacturers, promoting the adoption of non-invasive glucose meters among healthcare providers and patients. The increasing trend towards digital health and telemedicine in the Asia Pacific is further accelerating the demand for innovative healthcare solutions, including non-invasive glucose meters.

Competitive Landscape

The Non-Invasive Glucose Meter Market is a rapidly evolving field with numerous players vying for market share. While traditional invasive methods have dominated the market for decades, advancements in technology have led to increased interest in non-invasive alternatives. This competitive landscape is characterized by a mix of established medical device companies, innovative startups, and research institutions.

The organizations are focusing on innovating their product line to serve the vast population in diverse regions. Some of the prominent players operating in the non-invasive glucose meter market include:

Abbott
PHC Holdings Corporation
Sanofi
Dexcom, Inc.
Medtronic
Braun SE
Hoffmann-La Roche Ltd.
LifeScan
Ascensia Diabetes Care Holdings AG
AgaMatrix
DarioHealth
Becton Dickinson & Company

Latest Developments:

In February 2024, Dexcom, Inc. announced the launch of Dexcom ONE+, the latest Continuous Glucose Monitoring (CGM), to bring strong, new diabetes care technologies to patients in Belgium, Spain, and Poland.
In January 2024, Abbott and Tandem Diabetes Care, Inc., a player in insulin delivery and diabetes technologies, unveiled the t: slim X2 insulin pump with Control-IQ technology making it the first automated insulin administration system in the United States to combine with the
FreeStyle Libre 2 Plus sensor. This enabled the organization to strengthen its product portfolio.
In January 2024, Medtronic got CE approval for the MiniMed 780G system with Simplera Sync, a disposable, all-in-one Continuous Glucose Monitor (CGM) that does not require fingersticks or overtape, intending to strengthen its product line.
In September 2023, Nemaura Medical announced the completion of a clinical trial with 100 patients using the sugar beet, a non-invasive and flexible continuous glucose monitor. The study was carried out in the Middle East and included four groups, each with an equal number of male and female volunteers aged 18 to 75 years. Twenty of the patients had type 1 diabetes, with the others having type 2 diabetes.